The new signaling pathway ERK5/TP53INP2 sensitizes cancer cells to death-receptor agonists and Natural Killer cells https://www.biorxiv.org/content/10.1101/2023.03.22.533738v1?med=mas
The new signaling pathway ERK5/TP53INP2 sensitizes cancer cells to death-receptor agonists and Natural Killer cells https://www.biorxiv.org/content/10.1101/2023.03.22.533738v1?med=mas